DNA
Price
$11.15
Change
-$0.53 (-4.54%)
Updated
Sep 5 closing price
Capitalization
660.08M
TECX
Price
$16.80
Change
-$0.47 (-2.72%)
Updated
Sep 5 closing price
Capitalization
314.36M
Interact to see
Advertisement

DNA vs TECX

Header iconDNA vs TECX Comparison
Open Charts DNA vs TECXBanner chart's image
Ginkgo Bioworks Holdings
Price$11.15
Change-$0.53 (-4.54%)
Volume$2.09M
Capitalization660.08M
Tectonic Therapeutic
Price$16.80
Change-$0.47 (-2.72%)
Volume$683.69K
Capitalization314.36M
DNA vs TECX Comparison Chart in %
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNA vs. TECX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Buy and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (DNA: $11.15 vs. TECX: $16.80)
Brand notoriety: DNA and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 126% vs. TECX: 229%
Market capitalization -- DNA: $660.08M vs. TECX: $314.36M
DNA [@Biotechnology] is valued at $660.08M. TECX’s [@Biotechnology] market capitalization is $314.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, DNA is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 2 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 2 bullish, 6 bearish.
  • TECX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TECX is a better buy in the short-term than DNA.

Price Growth

DNA (@Biotechnology) experienced а -12.00% price change this week, while TECX (@Biotechnology) price change was -34.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($660M) has a higher market cap than TECX($314M). DNA YTD gains are higher at: 13.544 vs. TECX (-63.613). TECX has higher annual earnings (EBITDA): -63.29M vs. DNA (-292.97M). DNA has more cash in the bank: 474M vs. TECX (287M). TECX has less debt than DNA: TECX (1.94M) vs DNA (429M). DNA has higher revenues than TECX: DNA (231M) vs TECX (0).
DNATECXDNA / TECX
Capitalization660M314M210%
EBITDA-292.97M-63.29M463%
Gain YTD13.544-63.613-21%
P/E RatioN/A4.06-
Revenue231M0-
Total Cash474M287M165%
Total Debt429M1.94M22,079%
FUNDAMENTALS RATINGS
TECX: Fundamental Ratings
TECX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNATECX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDMGX20.900.34
+1.65%
Sit Developing Markets Growth
QTENX12.300.12
+0.99%
AQR Emerging Multi-Style II N
IUEFX29.130.12
+0.41%
JPMorgan International Focus R5
PRJCX41.050.05
+0.12%
PGIM Jennison Global Opportunities C
HMCNX15.400.01
+0.06%
Harbor Mid Cap Investor

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with VCYT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
-4.54%
VCYT - DNA
58%
Loosely correlated
+2.89%
RXRX - DNA
52%
Loosely correlated
+1.99%
ABCL - DNA
49%
Loosely correlated
+1.44%
CRSP - DNA
48%
Loosely correlated
+4.02%
ABSI - DNA
48%
Loosely correlated
+2.50%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-2.72%
IGC - TECX
49%
Loosely correlated
-0.98%
SRPT - TECX
35%
Loosely correlated
+1.35%
ATHE - TECX
35%
Loosely correlated
N/A
IMNM - TECX
35%
Loosely correlated
+7.35%
DNA - TECX
34%
Loosely correlated
-4.54%
More